FDA Approval
U.S. Food and Drug Administration Approves Opdivo®(nivolumab) as the First New Medication in Nearly 20 Years for Certain Patients with Previously Treated Small Cell Lung Cancer
Bristol-Myers Squibb
PR-M09-18-NI-065Sep 21, 2018
Collaboration
Amgen And MD Anderson Announce Collaboration To Accelerate Early Stage Treatments For Cancer
Amgen
PR-M06-18-NI-028Jun 08, 2018